vs
Ginkgo Bioworks Holdings, Inc.（DNA）与UNITY BANCORP INC（UNTY）财务数据对比。点击上方公司名可切换其他公司
UNITY BANCORP INC的季度营收约是Ginkgo Bioworks Holdings, Inc.的1.1倍（$35.3M vs $33.4M），UNITY BANCORP INC同比增速更快（24.2% vs -23.8%），UNITY BANCORP INC自由现金流更多（$44.3M vs $-47.7M），过去两年UNITY BANCORP INC的营收复合增速更高（17.5% vs -6.2%）
Ginkgo Bioworks Holdings, Inc.是一家2008年由五名麻省理工学院科学家创立的美国生物技术企业，由杰森·凯利掌舵。公司专注于基因工程改造，为其他生物科技企业开发具备工业应用价值的菌株，帮助合作方省去合成生物学设计初期的重复研发成本，号称「生物制造平台企业」，2019年估值就已达42亿美元。
Unity Bancorp Inc是总部位于美国新泽西州的金融控股公司，旗下运营Unity Bank，面向新泽西州及宾夕法尼亚州东部的本地社区，提供商业贷款、存款账户、抵押贷款、个人银行等全系列商业及零售银行服务，核心服务客群为中小企业和个人消费者。
DNA vs UNTY — 直观对比
营收规模更大
UNTY
是对方的1.1倍
$33.4M
营收增速更快
UNTY
高出48.0%
-23.8%
自由现金流更多
UNTY
多$92.0M
$-47.7M
两年增速更快
UNTY
近两年复合增速
-6.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $33.4M | $35.3M |
| 净利润 | — | $15.5M |
| 毛利率 | — | — |
| 营业利润率 | -211.9% | 55.8% |
| 净利率 | — | 43.9% |
| 营收同比 | -23.8% | 24.2% |
| 净利润同比 | — | 34.5% |
| 每股收益（稀释后） | $-1.41 | $1.52 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DNAUNTY
| Q4 25 | $33.4M | $35.3M | ||
| Q3 25 | $38.8M | $32.8M | ||
| Q2 25 | $49.6M | $34.4M | ||
| Q1 25 | $48.3M | $29.4M | ||
| Q4 24 | $43.8M | $28.4M | ||
| Q3 24 | $89.0M | $27.7M | ||
| Q2 24 | $56.2M | $25.5M | ||
| Q1 24 | $37.9M | $25.6M |
净利润DNAUNTY
| Q4 25 | — | $15.5M | ||
| Q3 25 | $-80.8M | $14.4M | ||
| Q2 25 | $-60.3M | $16.5M | ||
| Q1 25 | $-91.0M | $11.6M | ||
| Q4 24 | — | $11.5M | ||
| Q3 24 | $-56.4M | $10.9M | ||
| Q2 24 | $-217.2M | $9.5M | ||
| Q1 24 | $-165.9M | $9.6M |
营业利润率DNAUNTY
| Q4 25 | -211.9% | 55.8% | ||
| Q3 25 | -231.8% | 57.5% | ||
| Q2 25 | -132.1% | 62.6% | ||
| Q1 25 | -184.1% | 52.6% | ||
| Q4 24 | -236.3% | 51.0% | ||
| Q3 24 | -62.0% | 52.7% | ||
| Q2 24 | -396.7% | 49.3% | ||
| Q1 24 | -469.1% | 50.0% |
净利率DNAUNTY
| Q4 25 | — | 43.9% | ||
| Q3 25 | -207.9% | 43.8% | ||
| Q2 25 | -121.6% | 48.0% | ||
| Q1 25 | -188.2% | 39.5% | ||
| Q4 24 | — | 40.5% | ||
| Q3 24 | -63.3% | 39.4% | ||
| Q2 24 | -386.4% | 37.1% | ||
| Q1 24 | -437.3% | 37.5% |
每股收益（稀释后）DNAUNTY
| Q4 25 | $-1.41 | $1.52 | ||
| Q3 25 | $-1.45 | $1.41 | ||
| Q2 25 | $-1.10 | $1.61 | ||
| Q1 25 | $-1.68 | $1.13 | ||
| Q4 24 | $-1.91 | $1.13 | ||
| Q3 24 | $-1.08 | $1.07 | ||
| Q2 24 | $-4.23 | $0.92 | ||
| Q1 24 | $-3.32 | $0.94 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $422.6M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $508.6M | $345.6M |
| 总资产 | $1.1B | $3.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DNAUNTY
| Q4 25 | $422.6M | — | ||
| Q3 25 | $495.5M | — | ||
| Q2 25 | $559.4M | — | ||
| Q1 25 | $325.3M | — | ||
| Q4 24 | $561.6M | — | ||
| Q3 24 | $616.2M | — | ||
| Q2 24 | $730.4M | — | ||
| Q1 24 | $840.4M | — |
总债务DNAUNTY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $230.8M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益DNAUNTY
| Q4 25 | $508.6M | $345.6M | ||
| Q3 25 | $559.8M | $334.0M | ||
| Q2 25 | $613.0M | $319.8M | ||
| Q1 25 | $647.4M | $306.1M | ||
| Q4 24 | $716.1M | $295.6M | ||
| Q3 24 | $797.9M | $284.3M | ||
| Q2 24 | $833.1M | $273.4M | ||
| Q1 24 | $987.3M | $266.8M |
总资产DNAUNTY
| Q4 25 | $1.1B | $3.0B | ||
| Q3 25 | $1.2B | $2.9B | ||
| Q2 25 | $1.2B | $2.9B | ||
| Q1 25 | $1.3B | $2.8B | ||
| Q4 24 | $1.4B | $2.7B | ||
| Q3 24 | $1.5B | $2.6B | ||
| Q2 24 | $1.6B | $2.6B | ||
| Q1 24 | $1.6B | $2.6B |
负债/权益比DNAUNTY
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.78× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-47.7M | $44.9M |
| 自由现金流经营现金流 - 资本支出 | $-47.7M | $44.3M |
| 自由现金流率自由现金流/营收 | -142.8% | 125.7% |
| 资本支出强度资本支出/营收 | 0.0% | 1.6% |
| 现金转化率经营现金流/净利润 | — | 2.90× |
| 过去12个月自由现金流最近4个季度 | — | $81.7M |
8季度趋势，按日历期对齐
经营现金流DNAUNTY
| Q4 25 | $-47.7M | $44.9M | ||
| Q3 25 | $-31.6M | $45.5M | ||
| Q2 25 | $-40.3M | $-25.3M | ||
| Q1 25 | $-51.5M | $17.9M | ||
| Q4 24 | $-42.4M | $48.0M | ||
| Q3 24 | $-103.5M | $17.7M | ||
| Q2 24 | $-84.4M | $-8.4M | ||
| Q1 24 | $-89.3M | $15.8M |
自由现金流DNAUNTY
| Q4 25 | $-47.7M | $44.3M | ||
| Q3 25 | — | $45.3M | ||
| Q2 25 | $-40.3M | $-25.5M | ||
| Q1 25 | $-59.1M | $17.6M | ||
| Q4 24 | $-56.1M | $47.3M | ||
| Q3 24 | $-118.6M | $17.5M | ||
| Q2 24 | $-111.4M | $-8.6M | ||
| Q1 24 | $-96.0M | $15.7M |
自由现金流率DNAUNTY
| Q4 25 | -142.8% | 125.7% | ||
| Q3 25 | — | 138.1% | ||
| Q2 25 | -81.2% | -74.2% | ||
| Q1 25 | -122.4% | 59.9% | ||
| Q4 24 | -128.0% | 166.5% | ||
| Q3 24 | -133.2% | 63.3% | ||
| Q2 24 | -198.2% | -33.7% | ||
| Q1 24 | -252.9% | 61.4% |
资本支出强度DNAUNTY
| Q4 25 | 0.0% | 1.6% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | 0.1% | 0.5% | ||
| Q1 25 | 15.8% | 1.0% | ||
| Q4 24 | 31.3% | 2.4% | ||
| Q3 24 | 16.9% | 0.5% | ||
| Q2 24 | 48.1% | 0.5% | ||
| Q1 24 | 17.7% | 0.3% |
现金转化率DNAUNTY
| Q4 25 | — | 2.90× | ||
| Q3 25 | — | 3.16× | ||
| Q2 25 | — | -1.54× | ||
| Q1 25 | — | 1.54× | ||
| Q4 24 | — | 4.17× | ||
| Q3 24 | — | 1.62× | ||
| Q2 24 | — | -0.89× | ||
| Q1 24 | — | 1.64× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DNA
| Cell Engineering Segment | $26.0M | 78% |
| Other | $7.4M | 22% |
UNTY
暂无分部数据
